{"filing":{"accession_number":"0001213900-26-093566","cik":"0001505497","ticker":"BRTX","company_name":"BioRestorative Therapies, Inc.","form":"8-K","filing_date":"2026-08-25","report_date":"2026-08-21","primary_document":"ea0303388-8k_biorestorative.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1505497/000121390026093566/ea0303388-8k_biorestorative.htm"},"events":[{"id":29548,"run_id":27059,"accession_number":"0001213900-26-093566","anchor_item_number":"3.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"summary":"BioRestorative Therapies received a delinquency notification from Nasdaq on August 21, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until October 20, 2026, to submit a compliance plan and until February 16, 2027, to regain compliance, with explicit risk of delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.","company_name":"BioRestorative Therapies, Inc.","ticker":"BRTX","filing_date":"2026-08-25","form":"8-K","submitted_at":null,"items":[{"id":31865,"accession_number":"0001213900-26-093566","item_number":"3.01","item_title":"Notice of Delisting or Failure to","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"BioRestorative Therapies received a delinquency notification from Nasdaq on August 21, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until October 20, 2026, to submit a compliance plan and until February 16, 2027, to regain compliance, with explicit risk of delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T21:01:59.320415+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":31865,"accession_number":"0001213900-26-093566","item_number":"3.01","item_title":"Notice of Delisting or Failure to","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.98,"reasoning":"BioRestorative Therapies received a delinquency notification from Nasdaq on August 21, 2026, for failure to timely file its Form 10-Q, placing the company in non-compliance with Nasdaq Listing Rule 5250(c)(1). The company has until October 20, 2026, to submit a compliance plan and until February 16, 2027, to regain compliance, with explicit risk of delisting if it fails to do so. This is a classic delisting-risk disclosure under Item 3.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-25T21:01:59.320415+00:00","company_name":"BioRestorative Therapies, Inc.","ticker":"BRTX","filing_date":"2026-08-25"}]}